… for predicting nivolumab efficacy is crucial. We conducted a retrospective multicenter trial
to determine the significance of clinical factors as predictors of nivolumab efficacy in patients …

… In the present retrospective multicenter study of 142 patients with advanced NSCLC, we
have demonstrated the real-world efficacy and safety of nivolumab, a newly approved immune …

… a retrospective multicentre clinical study to examine the efficacy and safety of nivolumab in
… This study also examined the relationships between appearance of irAEs and both OS and …

… and nivolumab efficacy [[18], [19], [20]]. Therefore, accumulating a large amount of efficacy
and … The aim of this study was to investigate the efficacy and safety of nivolumab in previously …

… initial efficacy of LRTs performed in combination with nivolumab … This study describes safety
in a small, retrospective, single-center … HCC undergoing LRT concurrently with nivolumab. …

… trials. The aim of the present study was to investigate the efficacy and safety of nivolumab
for … In this observational monocentric retrospective study, 98 patients were enrolled between …

… nivolumab and describe its effectiveness and safety in a Japanese real-world setting. Therefore,
in this study, a multicenter retrospective … patients treated with nivolumab (study number: …

… To assess efficacy and toxicity of combination immunotherapy with ipilimumab plus
nivolumab in routine practice in a retrospective multicentre cohort of patients with advanced …

… nivolumab alone and clinical response remained unclear. Our multicenter retrospective study
… between irAEs induced by nivolumab in early phase and clinical efficacy in patients with …

… this study showed that nivolumab was most effective, in terms of ORR, PFS, and OS, in
patients with ECOG PS 0 status. Other studies utilizing anti-PD-1 inhibitors, including nivolumab, …